A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director, Pharmacovigilance & Safety Technology

Biology & BiotechPosted on Nov 10
Full-timeCambridge, MA, USA$187.4k - $253.6k

About the Job

Requirements

  • A degree in Information Technology, Computer Science, Data Science, Life Sciences, Pharmacy, or a related field, plus significant experience in regulated life sciences environments.
  • At least 12 years of experience in life sciences technology, pharmacovigilance systems, safety technology, drug safety operations technology, safety data management platforms, PV systems modernization, or related regulated technology roles.
  • Deep understanding of pharmacovigilance processes sufficient to lead technology design, governance, and delivery across safety databases such as Argus or comparable commercial safety platforms, case intake and processing workflows, regulatory reporting, signal detection tools, aggregate reporting, risk management, and safety analytics.
  • Working knowledge of global pharmacovigilance regulatory requirements and industry standards, including FDA and EMA requirements, ICH guidelines, 21 CFR Part 11, GxP validation, data integrity, MedDRA structure, and inspection-readiness expectations.
  • Significant experience shaping technology strategy and capability roadmaps in GxP-regulated environments, ideally across platforms, processes, data, integrations, reporting, and analytics workflows.
  • Ability to operate at strategic and technical depth, including evaluating architecture options, validation approaches, data integration strategies, reporting tools, vendor solutions, and operational support models.
  • Experience with pharmacovigilance technologies and adjacent tools such as safety gateways, reporting platforms, dashboards, Oracle or SQL-based data environments, analytics platforms, signal detection tools such as Empirica or Spotfire, and enterprise integration services.
  • Strong understanding of artificial intelligence, automation, advanced analytics, and responsible AI governance in regulated pharmacovigilance environments, including assessing use cases, validation needs, compliance risks, and adoption requirements.
  • Business analysis skills, including analytical and problem-solving abilities, prioritization, project management, and stakeholder management.
  • Ability to influence across Safety, Technology, Quality, Compliance, Data, vendors, and senior business stakeholders.
  • Oral and written communication skills sufficient to translate technical, regulatory, and compliance topics into clear business decisions and executive-ready recommendations.
  • People leadership experience, including direct responsibility for coaching, developing, and managing experienced technology professionals and building high-performing internal and partner delivery teams.

Responsibilities

  • Serve as the primary business technology functional leader and strategic partner for Safety & Risk Management, Safety Operations, Pharmacovigilance, Risk Management, and related safety functions; build trusted relationships with functional leadership to understand objectives, priorities, pain points, and technology needs.
  • Define and maintain the safety technology roadmap, translating Safety business priorities and requirements into prioritized platform investments, process-enabling technology capabilities, data enablement, automation, and AI-enabled solution opportunities.
  • Lead the technology direction, prioritization, and continuous improvement of platforms and workflows supporting end-to-end pharmacovigilance, including case management, regulatory reporting, signal and risk management, aggregate reporting, safety analytics, and related integrations.
  • Own the technology partnership model for supported safety functions, including demand shaping, prioritization, business case development, solution alignment, delivery oversight, adoption planning, operational readiness, and value realization.
  • Establish accountability across the Safety technology operating model: Safety owns business outcomes, processes, and requirements, while Technology owns solution strategy, platform oversight, delivery, governance, and operational reliability.
  • Establish and enforce technology governance, standards, and best practices, including data privacy, security, validation, records management, inspection readiness, 21 CFR Part 11, data integrity, and compliance with global pharmacovigilance regulatory requirements.
  • Partner with product owners, application teams, service providers, and vendors to align platform priorities, releases, validation, support models, and service performance with Safety business needs.
  • Lead, coach, and develop a team of technology professionals by establishing accountabilities, priorities, performance expectations, and development plans, and build an effective operating model across internal teams, vendors, and delivery partners.
  • Provide technology leadership in the design and evolution of pharmacovigilance systems, safety data models, integrations, reporting architecture, analytics capabilities, dashboards, workflow automation, and platform interoperability across the safety ecosystem.
  • Partner with Data and Analytics teams to enable cross-system reporting, traceability, compliance metrics, quality performance indicators, signal detection, and safety insights while maintaining clear data ownership, security, privacy, and compliance boundaries.
  • Enable and govern technology capabilities used by Safety teams for case intake, triage, medical review, narrative support, expedited reporting, aggregate reporting, signal management, risk management, literature surveillance, inspection readiness, and global submission obligations.
  • Evaluate and govern emerging digital, automation, analytics, and AI-enabled capabilities for pharmacovigilance, balancing business value with validation, compliance, responsible-use, and adoption requirements.
  • Translate complex technical, safety, regulatory, validation, and compliance considerations into clear guidance, decisions, and tradeoffs for functional leadership and operational teams.
  • Collaborate with Clinical Development, Clinical Operations, Regulatory, Quality, Medical Affairs, Commercial, Patient Services, Data, and enterprise Technology teams so safety systems integrate effectively across the product lifecycle and support investigational and post-marketing obligations.
  • Enable global pharmacovigilance operations through technology solutions that scale across regions, affiliates, partners, vendors, products, studies, programs, reporting destinations, and evolving regulatory expectations.
  • Partner with Quality, Security, Privacy, Records Management, Compliance, Validation, and Safety leadership to ensure technology solutions meet internal procedures, global regulatory expectations, audit requirements, and inspection-readiness standards.
  • Collaborate with external safety system vendors, product owners, application support teams, managed service providers, and enterprise technology partners to deliver system implementations, integrations, upgrades, enhancements, migrations, reporting capabilities, and technology-enabled operational improvements for pharmacovigilance and Safety.
  • Guide delivery and support partners with sufficient functional and technical depth to challenge solution designs, assess architecture and data tradeoffs, and ensure delivered capabilities meet compliance, scalability, usability, integration, and operational support standards.
  • Identify system, data, reporting, integration, workflow, and technical gaps in safety systems and recommend pragmatic technology improvements that reduce operational burden and strengthen compliance.
  • Apply root cause analysis to resolve complex technology issues affecting case processing, regulatory reporting, safety data quality, integrations, system performance, or operational delivery.
  • Act as the technology escalation point for critical system issues impacting pharmacovigilance, Safety Operations, regulatory reporting, signal detection, inspection readiness, or safety business continuity.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs